Keefe, Bruyette & Woods Maintains Outperform on Globe Life, Lowers Price Target to $190
Keefe, Bruyette & Woods analyst Ryan Krueger maintains Globe Life (NYSE:GL) with a Outperform and lowers the price target from $192 to $190.
Stocks · News reference
Globe Life Q2 Adj. EPS $3.61 Misses $3.68 Estimate, Sales $1.600B Beat $1.589B Estimate
Globe Life (NYSE:GL) reported quarterly earnings of $3.61 per share which missed the analyst consensus estimate of $3.68 by 1.9 percent. This is a 10.4 percent increase over earnings of $3.27 per share from the same
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Full Transcript: Globe Life Q2 2026 Earnings Call
Globe Life (NYSE:GL) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire
Globe Life shares are trading lower after the company reported mixed Q2 financial results.
Globe Life Raises FY2026 Adj EPS Guidance from $15.40-$15.90 to $15.55-$15.95 vs $15.64 Est
Globe Life (NYSE:GL) raises FY2026 Adj EPS guidance from $15.40-$15.90 to $15.55-$15.95 vs $15.64 analyst estimate..